Dovitinib Plus an Aromatase Inhibitor for Metastatic Breast Cancer
Clinical trial NCT01484041 · TERMINATED
Trial details
- NCT number
- NCT01484041
- Sponsor
- Georgetown University
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2015-12-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.